Home » Topics » BioWorld Science

BioWorld Science
RSS

Phase I safety and PK data presented for novel CXCR4 antagonist YF-H-2015005

Oct. 4, 2019

TERT gene fusions as novel biomarkers in metastatic Leydig cell tumors

Oct. 4, 2019

AL-008 potentiates the antitumor effector functions of macrophages and dendritic cells

Oct. 4, 2019

FDA approves Entresto for pediatric heart failure

Oct. 4, 2019

Allogene Therapeutics initiates phase I study of ALLO-715

Oct. 4, 2019

Targeting ATP6V1A subunit in the v-ATPase complex inhibits mTORC1 signaling and activates autophagy

Oct. 4, 2019

Phase II data show efficacy of TTP-399 as an adjunctive therapy for type 1 diabetes

Oct. 3, 2019

Actinogen reports cognition data on Xanamem in healthy elderly subjects

Oct. 3, 2019

Phase III THEMIS-PCI results on ticagrelor published

Oct. 3, 2019

XBiotech initiates phase II study of bermekimab in systemic sclerosis

Oct. 3, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 16, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
CTAD 2025: The challenges of combination therapies for dementia
BioWorld Science
At the Clinical Trials on Alzheimer’s Disease 2025 meeting, a panel of experts discussed the need for developing combination therapies for the complex diseases...